BioCardia regains Nasdaq minimum bid price compliance; matter closed

BioCardia, Inc.

On Sept 21, 2026, Nasdaq notified BioCardia its closing bid price was ≥$1.00 for 10 straight business days.
Company had been below $1.00 minimum bid for 30 consecutive days as of Aug 19, 2026.
Regained compliance under Listing Rule 5550(a)(2); delisting matter resolved.
Common stock (BCDA) continues trading on Nasdaq Capital Market; no trading impact.
Company cautions it may not maintain compliance in the future.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.